Translational Medicine in Drug Development - How to Implement a Biomarker Strategy in a Clinical Trial
Complete the form to view the recording.Share this resource:
Now Streaming On-Demand
In association with Oxford Global, this webinar will highlight how to properly structure your program and get an in-depth look at the critical parameters needed for a fit-for-purpose approach. You will learn the key assay validation parameters to produce a reliable bioanalytical assay generating data for your decision-making.
About the Presenter:
Marianne Scheel Fjording is a Scientific Officer at BioAgilytix. Marianne has an extensive background in large molecule bioanalytical assay set-up and assay validation. She has 20+ years of experience working in the pharmaceutical and biotechnology industry. Prior to joining BioAgilytix, she was Scientific Director at Novo Nordisk (Copenhagen, Denmark) where she delivered bioanalytical strategies for PK and biomarker assays.